The Condition Known as PCOS Has a New Name
Time Magazine • • general
Key Points:
- Polycystic ovary syndrome (PCOS), named a century ago due to the appearance of sacs on ovaries, is now understood as a broader endocrine disorder affecting metabolism, cardiovascular health, and skin, not just ovarian cysts.
- The sacs initially thought to be cysts are actually arrested egg follicles, and new diagnostic guidelines no longer require ovarian examination, reflecting the disorder’s systemic nature.
- A recent Lancet paper announced the renaming of PCOS to polyendocrine metabolic ovarian syndrome (PMOS) to better represent its complex hormonal and metabolic impacts and improve research funding and patient understanding.
- The name change aims to shift clinical focus beyond fertility to include early cardiovascular and metabolic risks, especially in adolescents, addressing gaps in current screening and treatment practices.
- The new diagnostic criteria for PMOS focus on excess androgens, irregular menstrual cycles, and elevated anti-mullerian hormone or ultrasound findings, with a trend toward less reliance on ultrasounds; the name change is expected to be adopted internationally by 2028.